Therapeutic effects of a 12-week course of alefacept on nail psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 10, 2006, Pages 1252-1255

  Korver J E M ^a   Langewouters, A M G ^a   Van De Kerkhof, P C M ^a   Pasch, M C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alefacept; Nails; NAPSI; PASI; Psoriasis; Treatment

Indexed keywords

ALEFACEPT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MALE; MEDICAL PHOTOGRAPHY; NAIL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; TREATMENT DURATION;

ADULT; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NAILS; PSORIASIS; RECOMBINANT FUSION PROTEINS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33750360287     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01783.x     Document Type: Article

References (18)

1. Salomon J, Szepietowski JC, Proniewicz A. Psoriatic nails: A prospective clinical study. J Cutan Med Surg 2003; 7: 317-321.
2. de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van De Kerkhof PC. Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1,728 patients. Dermatology 1996; 193: 300-303.
3. Murdan S. Drug delivery to the nail following topical application. Int J Pharm 2002; 236: 1-26.
4. de Berker DA, Lawrence CM. A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol 1998; 138: 90-95.
5. de Berker D. Management of nail psoriasis. Clin Exp Dermatol 2000; 25: 357-362.
6. Feliciani C, Zampetti A, Forleo P et al. Nail psoriasis: Combined therapy with systemic cyclosporin and topical calcipotriol. J Cutan Med Surg 2004; 8: 122-125.
7. Mahrle G, Schulze HJ, Farber L, Weidinger G, Steigleder GK. Low-dose short-term cyclosporine versus etretinate in psoriasis: Improvement of skin, nail, and joint involvement. J Am Acad Dermatol 1995; 32: 78-88.
8. Bianchi L, Bergamin A, de Felice C, Capriotti E, Chimenti S. Remission and time of resolution of nail psoriasis during infliximab therapy. J Am Acad Dermatol 2005; 52: 736-737.
9. Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 2002; 47: 821-833.
10. Ellis CN, Krueger GG. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 2001; 345: 248-255.
11. Cassetty CT, Alexis AF, Shupack JL, Strober BE. Alefacept in the treatment of psoriatic nail disease: A small case series. J Am Acad Dermatol 2005; 52: 1101-1102.
12. Rich P, Scher RK. Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003; 49: 206-212.
13. Cannavo SP, Guarneri F, Vaccaro M, Borgia F, Guarneri B. Treatment of psoriatic nails with topical cyclosporin: A prospective, randomized placebo-controlled study. Dermatology 2003; 206: 153-156.
14. Obadiah J, Scher R. Nail disorders: Unapproved treatments. Clin Dermatol 2002; 20: 643-648.
15. Gottlieb AB, Evans R, Li S et al. Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2004; 51: 534-542.
16. de Jong EM, Menke HE, van Praag MC, van De Kerkhof PC. Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: A double-blind study. Dermatology 1999; 199: 313-318.
17. Tosti A, Piraccini BM, Cameli N et al. Calcipotriol ointment in nail psoriasis: A controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 1998; 139: 655-659.
18. Pierard GE, Pierard-Franchimont C. Dynamics of psoriatic trachyonychia during low-dose cyclosporin A treatment: A pilot study on onychochronobiology using optical profilometry. Dermatology 1996; 192: 116-119.